Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.7350
+0.0571 (8.42%)
Dec 10, 2025, 9:39 AM EST - Market open
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $30.01 million as of December 10, 2025. Its market cap has decreased by -17.02% in one year.
Market Cap
30.01M
Enterprise Value
-35.02M
1-Year Change
-17.02%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $30.01M, a decrease of -94.82%. That is a compound annual growth rate of -47.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 28.70M | -40.95% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | 579.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |